Works matching IS 11707690 AND DT 2022 AND VI 40 AND IP 3

Results: 10

Correction to: Public Preferences for a COVID-19 Vaccination Program in Quebec: A Discrete Choice Experiment.
Published in:
PharmacoEconomics, 2022, v. 40, n. 3, p. 357, doi. 10.1007/s40273-022-01134-w
By:
- Morillon, Gabin F.;
- Poder, Thomas G.
Publication type:
Article
Correction to: Contextual Considerations and Recommendations for Estimating the Value of Alzheimer's Disease Therapies.
Published in:
2022
By:
- Mattingly II, T. Joseph;
- McQueen, R. Brett;
- Lin, Pei-Jung
Publication type:
Correction Notice
Public Preferences for a COVID-19 Vaccination Program in Quebec: A Discrete Choice Experiment.
Published in:
PharmacoEconomics, 2022, v. 40, n. 3, p. 341, doi. 10.1007/s40273-021-01124-4
By:
- Morillon, Gabin F.;
- Poder, Thomas G.
Publication type:
Article
Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations.
Published in:
PharmacoEconomics, 2022, v. 40, n. 3, p. 269, doi. 10.1007/s40273-021-01120-8
By:
- Romano, Sónia;
- Figueira, Débora;
- Teixeira, Inês;
- Perelman, Julian
Publication type:
Article
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time.
Published in:
PharmacoEconomics, 2022, v. 40, n. 3, p. 249, doi. 10.1007/s40273-021-01116-4
By:
- Shields, Gemma E.;
- Pennington, Becky;
- Bullement, Ash;
- Wright, Stuart;
- Elvidge, Jamie
Publication type:
Article
Conceptual Framework and Methodological Challenges for Modeling Effectiveness in Oncology Treatment Sequence Models.
Published in:
PharmacoEconomics, 2022, v. 40, n. 3, p. 257, doi. 10.1007/s40273-021-01113-7
By:
- Huang, Min;
- Ramsey, Scott;
- Xue, Weiguang;
- Xie, Jipan;
- Pellissier, James;
- Briggs, Andrew
Publication type:
Article
Four Aspects Affecting Health Economic Decision Models and Their Validation.
Published in:
PharmacoEconomics, 2022, v. 40, n. 3, p. 241, doi. 10.1007/s40273-021-01110-w
By:
- Feenstra, Talitha;
- Corro-Ramos, Isaac;
- Hamerlijnck, Dominique;
- van Voorn, George;
- Ghabri, Salah
Publication type:
Article
A Comparison of PROPr and EQ-5D-5L Value Sets.
Published in:
PharmacoEconomics, 2022, v. 40, n. 3, p. 297, doi. 10.1007/s40273-021-01109-3
By:
- Pan, Tianxin;
- Mulhern, Brendan;
- Viney, Rosalie;
- Norman, Richard;
- Hanmer, Janel;
- Devlin, Nancy
Publication type:
Article
Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom.
Published in:
PharmacoEconomics, 2022, v. 40, n. 3, p. 323, doi. 10.1007/s40273-021-01106-6
By:
- Spelman, Timothy;
- Herring, William L.;
- Zhang, Yuanhui;
- Tempest, Michael;
- Pearson, Isobel;
- Freudensprung, Ulrich;
- Acosta, Carlos;
- Dort, Thibaut;
- Hyde, Robert;
- Havrdova, Eva;
- Horakova, Dana;
- Trojano, Maria;
- De Luca, Giovanna;
- Lugaresi, Alessandra;
- Izquierdo, Guillermo;
- Grammond, Pierre;
- Duquette, Pierre;
- Alroughani, Raed;
- Pucci, Eugenio;
- Granella, Franco
Publication type:
Article
Developing the EQ-5D-5L Value Set for Uganda Using the 'Lite' Protocol.
Published in:
PharmacoEconomics, 2022, v. 40, n. 3, p. 309, doi. 10.1007/s40273-021-01101-x
By:
- Yang, Fan;
- Katumba, Kenneth R.;
- Roudijk, Bram;
- Yang, Zhihao;
- Revill, Paul;
- Griffin, Susan;
- Ochanda, Perez N.;
- Lamorde, Mohammed;
- Greco, Giulia;
- Seeley, Janet;
- Sculpher, Mark
Publication type:
Article